HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions

Cancer Research

Volumn 58, Issue 4, 1998, Pages 737-742

  Vitale, Marco ^a   Rezzani, Rita ^a   Rodella, Luigi ^a   Zauli, Giorgio ^b   Grigolato, Piergiovanni ^a   Cadei, Moris ^a   Hicklin, Daniel J ^c   Ferrone, Soldano ^c  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; BREAST CARCINOMA; CANCER GRADING; COMPLEX FORMATION; DIMERIZATION; ENDOPLASMIC RETICULUM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOTHERAPY; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN TRANSPORT; RECEPTOR DOWN REGULATION;

ANTIGEN PRESENTATION; ATP-BINDING CASSETTE TRANSPORTERS; BREAST NEOPLASMS; DOWN-REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS;

EID: 0032520053     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Germain, R.N. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell, 76: 287-299, 1994.
2. Rosenberg, S. A. Cancer vaccines based on the identification of genes encoding cancer regression antigens. Immunol. Today, 18: 175-182, 1997.
3. Natali, P. G., Giacomini, P., Bigotti, A., Imai, K., Nicotra, M. R., Ng, A. K., and Ferrone, S. Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells. Cancer Res., 43: 660-668, 1983.
4. Perez, M., Cabrera, T., Lopez Nevot, M. A., Gomez, M., Peran, F., Ruiz Cabello, F., and Garrido, F. Heterogeneity of the expression of class I and II HLA antigens in human breast carcinoma. J. Immunogenet., 13: 247-253, 1986.
5. Concha, A., Esteban, F., Cabrera, T., Ruiz Cabello, F., and Garrido, F. Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer. Semin. Cancer Biol., 2: 47-54, 1991.
6. Cordon-Cardo, C., Fuks, Z., Drobnjak, M., Moreno, C., Eisenbach, L., and Feldman, M. Expression of HLA-A, -B, -C antigens on primary and metastatic tumor cell populations of human carcinomas. Cancer Res., 51: 6372-6380, 1991.
7. Goepel, J. R., Rees, R. C., Rogers, K., Stoddard, C. J., Thomas, W. E., and Shepherd, L. Loss of monomorphic and polymorphic HLA antigens in metastatic breast and colon carcinoma. Br. J. Cancer, 64: 880-883, 1991.
8. Cabrera, T., Angustias Fernandez, M., Sierra, A., Garrido, A., Herruzo, A., Escobedo, A., Fabra, A., and Garrido, F. High frequency of altered HLA class I phenotypes in invasive breast carcinomas. Hum. Immunol., 50: 127-134, 1996.
9. Kaklamanis, L., Leek, R., Koukourakis, M., Gatter, K. C., and Harris, A. L. Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic versus primary breast cancer. Cancer Res., 55: 5191-5194, 1995.
10. Dalton, L. W., Page, D. L., and Dupont, W. D. Histological grading of breast carcinoma: a reproducibility study. Cancer (Phila.), 73: 2765-2770, 1994.
11. Dellaratta, D. V., Hicklin, D. J., Kishore, R., Kageshita, T., and Ferrone, S. Characterization of rabbit antisera elicited with human LMP2-and LMP7-specific peptides and recombinant proteins. Tissue Antigens, 50: 567-575, 1997.
12. Hicklin, D. J., Kageshita, T., and Ferrone, S. Development and characterization of rabbit antisera to human MHC-linked transporters associated with antigen processing. Tissue Antigens, 48: 38-46, 1996.
13. Stam, N. J., Spits, H., and Ploegh, H. L. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J. Immunol., 137: 2299-2306, 1986.
14. Zhu, X., Bavari, S., Ulrich, R., Sadegh-Nasseri, S., Ferrone, S., McHugh, L., and Mage, M. A recombinant single chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of α chain, β chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens. Eur. J. Immunol., 27: 1993-1941, 1997.
15. Hedley, D. W., Friedlander, M. L., Taylor, I. W., Rugg, C. A., and Musgrove, E. A. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J. Histochem. Cytochem., 31: 1333-1335, 1983.
16. Parham, P., Barnstable, C. J., and Bodmer, W. F. Use of a monoclonal antibody (W6/32) in structural studies of HLA-A,B,C, antigens. J. Immunol., 123: 342-349, 1979.
17. Kageshita, T., Hirai, S., Ono, T. and Ferrone, S. Comparison of the reactivity of frozen and formalin-fixed, paraffin-embedded sections of melanoma lesions with anti-HLA class I mAb. In: D. Charron (ed.), HLA. Genetic Diversity of HLA. Functional and Medical Implication. Proceedings of the Twelfth International Histocompatibility Workshop and Conference, Vol. II, pp. 737-739. Sevres, France: EDK, 1997.
18. Cromme, F. V., Van Bommel, P. F. J., Walboomers, J. M. M., Galle, T. J. M., Stern, P. L., Kenemans, P., Helmerhorst, T. J. M., Stukart, M. J., and Meijer, C. J. L. M. Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumors. Br. J Cancer, 69: 1176-1181, 1994.
19. Cromme, F. V., Airey, J., Heemels, M-T., Ploegh, H. L., Keating, P. J., Stern, P. L., Meijer, C. J. L. M., and Walboomers, J. M. M. Loss of transporter protein, encoded by the TAP-I gene, is highly correlated with loss of HLA expression in cervical carcinomas. J. Exp. Med., 179: 335-340, 1994.
20. Kaklamanis, L., Townsend, A., Doussis-Anagnostopoulou, I. A., Mortensen, N., Harris, A. L., and Gatter, K. C. Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer. Am. J. Pathol., 145: 505-509, 1994.
21. Korkolopoulou, P., Kaklamanis, L., Pezzella, F., Harris, A. L., and Gatter, K. C. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer. Br. J. Cancer, 73: 148-153, 1996.
22. Hicklin, D. J., Kageshita, T., Dellaratta, D. V., Boccaletti, V., and Ferrone, S. Defects in HLA class I antigen presentation machinery in melanoma cells. In: M. Maio (ed.), Immunology of Human Melanoma. Tumor-Host Interaction and Immunotherapy, pp. 95-111. Washington, DC: IOS Press, 1996.